{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T13:31:19Z","timestamp":1795008679865,"version":"4.9.1"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T00:00:00Z","timestamp":1650412800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T00:00:00Z","timestamp":1650412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["NWO-VIDI 864.13.009"],"award-info":[{"award-number":["NWO-VIDI 864.13.009"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Drug resistance and a dire lack of transmission-blocking antimalarials hamper malaria elimination. Here, we present the pantothenamide MMV693183 as a first-in-class acetyl-CoA synthetase (AcAS) inhibitor to enter preclinical development. Our studies demonstrate attractive drug-like properties and in vivo efficacy in a humanized mouse model of\n                    <jats:italic>Plasmodium falciparum<\/jats:italic>\n                    infection. The compound shows single digit nanomolar in vitro activity against\n                    <jats:italic>P. falciparum<\/jats:italic>\n                    and\n                    <jats:italic>P. vivax<\/jats:italic>\n                    clinical isolates, and potently blocks\n                    <jats:italic>P. falciparum<\/jats:italic>\n                    transmission to\n                    <jats:italic>Anopheles<\/jats:italic>\n                    mosquitoes. Genetic and biochemical studies identify AcAS as the target of the MMV693183-derived antimetabolite, CoA-MMV693183. Pharmacokinetic-pharmacodynamic modelling predict that a single 30\u2009mg oral dose is sufficient to cure a malaria infection in humans. Toxicology studies in rats indicate a\u2009&gt;\u200930-fold safety margin in relation to the predicted human efficacious exposure. In conclusion, MMV693183 represents a promising candidate for further (pre)clinical development with a novel mode of action for treatment of malaria and blocking transmission.\n                  <\/jats:p>","DOI":"10.1038\/s41467-022-29688-5","type":"journal-article","created":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T06:03:14Z","timestamp":1650434594000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Preclinical characterization and target validation of the antimalarial pantothenamide MMV693183"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3930-3311","authenticated-orcid":false,"given":"Laura E.","family":"de Vries","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick A. M.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalina","family":"Barcelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Munro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0573-1801","authenticated-orcid":false,"given":"Julie M. J.","family":"Verhoef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9780-3680","authenticated-orcid":false,"given":"Charisse Flerida A.","family":"Pasaje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Rubiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4673-3114","authenticated-orcid":false,"given":"Josefine","family":"Striepen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada","family":"Abla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8802-8195","authenticated-orcid":false,"given":"Luuk","family":"Berning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith M.","family":"Bolscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9610-2962","authenticated-orcid":false,"given":"Claudia","family":"Demarta-Gatsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob W. M.","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonnie","family":"Huijs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin M. J.","family":"Koolen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick K.","family":"Tumwebaze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2923-6060","authenticated-orcid":false,"given":"Tomas","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna C. C.","family":"Aguiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8800-8132","authenticated-orcid":false,"given":"I\u00f1igo","family":"Angulo-Barturen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4726-6397","authenticated-orcid":false,"given":"Alisje","family":"Churchyard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0275-352X","authenticated-orcid":false,"given":"Jake","family":"Baum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benigno Crespo","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco-Javier","family":"Gamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7187-0818","authenticated-orcid":false,"given":"Rafael V. C.","family":"Guido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Bel\u00e9n","family":"Jim\u00e9nez-Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7761-5498","authenticated-orcid":false,"given":"Dhelio B.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary","family":"Rochford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5119-0655","authenticated-orcid":false,"given":"Camille","family":"Roesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0796-5211","authenticated-orcid":false,"given":"Laura M.","family":"Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Trevitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Witkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Wittlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland A.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J.","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Sauerwein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1308-1319","authenticated-orcid":false,"given":"Joost","family":"Schalkwijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro H. H.","family":"Hermkens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger V.","family":"Bonnert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6425-5577","authenticated-orcid":false,"given":"Brice","family":"Campo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6753-8938","authenticated-orcid":false,"given":"David A.","family":"Fidock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6173-5882","authenticated-orcid":false,"given":"Manuel","family":"Llin\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6250-8796","authenticated-orcid":false,"given":"Jacquin C.","family":"Niles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8547-7523","authenticated-orcid":false,"given":"Taco W. A.","family":"Kooij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8124-4634","authenticated-orcid":false,"given":"Koen J.","family":"Dechering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,20]]},"reference":[{"key":"29688_CR1","unstructured":"WHO. World Malaria Report 2020. 2020."},{"key":"29688_CR2","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nm.4381","volume":"23","author":"B Blasco","year":"2017","unstructured":"Blasco, B., Leroy, D. & Fidock, D. A. Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic. Nat. Med. 23, 917\u2013928. (2017).","journal-title":"Nat. Med."},{"key":"29688_CR3","doi-asserted-by":"publisher","first-page":"e338","DOI":"10.1016\/S1473-3099(19)30261-0","volume":"19","author":"MD Conrad","year":"2019","unstructured":"Conrad, M. D. & Rosenthal, P. J. Antimalarial drug resistance in Africa: the calm before the storm? Lancet Infect. Dis. 19, e338\u2013e51. (2019).","journal-title":"Lancet Infect. Dis."},{"key":"29688_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-016-1675-x","volume":"16","author":"JN Burrows","year":"2017","unstructured":"Burrows, J. N. et al. New developments in anti-malarial target candidate and product profiles. Malar. J. 16, 26 (2017).","journal-title":"Malar. J."},{"key":"29688_CR5","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.plipres.2005.04.001","volume":"44","author":"R Leonardi","year":"2005","unstructured":"Leonardi, R., Zhang, Y. M., Rock, C. O. & Jackowski, S. Coenzyme A: back in action. Prog. Lipid Res. 44, 125\u2013153. (2005).","journal-title":"Prog. Lipid Res."},{"key":"29688_CR6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1550-7408.1985.tb03013.x","volume":"32","author":"AA Divo","year":"1985","unstructured":"Divo, A. A., Geary, T. G., Davis, N. L. & Jensen, J. B. Nutritional requirements of Plasmodium falciparum in culture. I. Exogenously supplied dialyzable components necessary for continuous growth. J. Protozool. 32, 59\u201364 (1985).","journal-title":"J. Protozool."},{"key":"29688_CR7","doi-asserted-by":"publisher","first-page":"200","DOI":"10.2174\/187152610791163390","volume":"10","author":"C Spry","year":"2010","unstructured":"Spry, C., van Schalkwyk, D. A., Strauss, E. & Saliba, K. J. Pantothenate utilization by Plasmodium as a target for antimalarial chemotherapy. Infect. Disord. Drug Targets 10, 200\u2013216. (2010).","journal-title":"Infect. Disord. Drug Targets"},{"key":"29688_CR8","doi-asserted-by":"publisher","first-page":"e1010124","DOI":"10.1371\/journal.ppat.1010124","volume":"17","author":"LE de Vries","year":"2021","unstructured":"de Vries, L. E., Lunghi, M., Krishnan, A., Kooij, T. W. A. & Soldati-Favre, D. Pantothenate and CoA biosynthesis in Apicomplexa and their promise as antiparasitic drug targets. PLoS Pathog. 17, e1010124 (2021).","journal-title":"PLoS Pathog."},{"key":"29688_CR9","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/j.1574-6976.2007.00093.x","volume":"32","author":"C Spry","year":"2008","unstructured":"Spry, C., Kirk, K. & Saliba, K. J. Coenzyme A biosynthesis: an antimicrobial drug target. FEMS Microbiol Rev. 32, 56\u2013106 (2008).","journal-title":"FEMS Microbiol Rev."},{"key":"29688_CR10","doi-asserted-by":"publisher","first-page":"e54974","DOI":"10.1371\/journal.pone.0054974","volume":"8","author":"C Spry","year":"2013","unstructured":"Spry, C. et al. Pantothenamides are potent, on-target inhibitors of Plasmodium falciparum growth when serum pantetheinase is inactivated. PLoS ONE 8, e54974 (2013).","journal-title":"PLoS ONE"},{"key":"29688_CR11","doi-asserted-by":"publisher","first-page":"4794","DOI":"10.1128\/AAC.00603-13","volume":"57","author":"PA Jansen","year":"2013","unstructured":"Jansen, P. A. et al. Combination of pantothenamides with vanin inhibitors as a novel antibiotic strategy against gram-positive bacteria. Antimicrob. Agents Chemother. 57, 4794\u20134800. (2013).","journal-title":"Antimicrob. Agents Chemother."},{"key":"29688_CR12","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1021\/ml400180d","volume":"4","author":"M de Villiers","year":"2013","unstructured":"de Villiers, M. et al. Structural modification of pantothenamides counteracts degradation by pantetheinase and improves antiplasmodial activity. ACS Med Chem. Lett. 4, 784\u2013789 (2013).","journal-title":"ACS Med Chem. Lett."},{"key":"29688_CR13","doi-asserted-by":"crossref","unstructured":"Spry C., et al. Towards a stable and potent coenzyme A-targeting antiplasmodial agent: structure-activity relationship studies of N-phenethyl-alpha-methyl-pantothenamide. ACS Infect. Dis. 6, 1844\u22121854 (2020).","DOI":"10.1021\/acsinfecdis.0c00075"},{"key":"29688_CR14","doi-asserted-by":"publisher","first-page":"7146","DOI":"10.1128\/AAC.01436-16","volume":"60","author":"VM Howieson","year":"2016","unstructured":"Howieson, V. M. et al. Triazole Substitution of a Labile Amide Bond Stabilizes Pantothenamides and Improves Their Antiplasmodial Potency. Antimicrob. Agents Chemother. 60, 7146\u20137152. (2016).","journal-title":"Antimicrob. Agents Chemother."},{"key":"29688_CR15","doi-asserted-by":"crossref","unstructured":"Schalkwijk J., et al. Antimalarial pantothenamide metabolites target acetyl-coenzyme A biosynthesis in Plasmodium falciparum. Sci. Transl Med. 11, eaas9917 (2019).","DOI":"10.1126\/scitranslmed.aas9917"},{"key":"29688_CR16","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/s41429-019-0196-6","volume":"72","author":"PAM Jansen","year":"2019","unstructured":"Jansen, P. A. M. et al. Stable pantothenamide bioisosteres: novel antibiotics for Gram-positive bacteria. J. Antibiot. (Tokyo) 72, 682\u2013692. (2019).","journal-title":"J. Antibiot. (Tokyo)"},{"key":"29688_CR17","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1021\/acsinfecdis.7b00240","volume":"4","author":"L Barnard","year":"2018","unstructured":"Barnard, L., Mostert, K. J., van Otterlo, W. A. L. & Strauss, E. Developing Pantetheinase-Resistant Pantothenamide Antibacterials: Structural Modification Impacts on PanK Interaction and Mode of Action. ACS Infect. Dis. 4, 736\u2013743. (2018).","journal-title":"ACS Infect. Dis."},{"key":"29688_CR18","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1021\/acsinfecdis.8b00113","volume":"4","author":"JB Radke","year":"2018","unstructured":"Radke, J. B., Burrows, J. N., Goldberg, D. E. & Sibley, L. D. Evaluation of Current and Emerging Antimalarial Medicines for Inhibition of Toxoplasma gondii Growth in Vitro. ACS Infect. Dis. 4, 1264\u20131274 (2018).","journal-title":"ACS Infect. Dis."},{"key":"29688_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/srep33518","volume":"6","author":"RJ Hart","year":"2016","unstructured":"Hart, R. J. et al. Genetic Characterization of Plasmodium Putative Pantothenate Kinase Genes Reveals Their Essential Role in Malaria Parasite Transmission to the Mosquito. Sci. Rep. 6, 33518 (2016).","journal-title":"Sci. Rep."},{"key":"29688_CR20","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3389\/fcimb.2017.00260","volume":"7","author":"RJ Hart","year":"2017","unstructured":"Hart, R. J., Abraham, A. & Aly, A. S. I. Genetic Characterization of Coenzyme A Biosynthesis Reveals Essential Distinctive Functions during Malaria Parasite Development in Blood and Mosquito. Front Cell Infect. Microbiol. 7, 260 (2017).","journal-title":"Front Cell Infect. Microbiol."},{"key":"29688_CR21","doi-asserted-by":"publisher","first-page":"e1006918","DOI":"10.1371\/journal.ppat.1006918","volume":"14","author":"ET Tjhin","year":"2018","unstructured":"Tjhin, E. T. et al. Mutations in the pantothenate kinase of Plasmodium falciparum confer diverse sensitivity profiles to antiplasmodial pantothenate analogues. PLoS Pathog. 14, e1006918 (2018).","journal-title":"PLoS Pathog."},{"key":"29688_CR22","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1021\/acsinfecdis.7b00024","volume":"3","author":"M de Villiers","year":"2017","unstructured":"de Villiers, M. et al. Antiplasmodial Mode of Action of Pantothenamides: Pantothenate Kinase Serves as a Metabolic Activator Not as a Target. ACS Infect. Dis. 3, 527\u2013541. (2017).","journal-title":"ACS Infect. Dis."},{"key":"29688_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-14074-9","volume":"7","author":"JE Chiu","year":"2017","unstructured":"Chiu, J. E. et al. The antimalarial activity of the pantothenamide alpha-PanAm is via inhibition of pantothenate phosphorylation. Sci. Rep. 7, 14234 (2017).","journal-title":"Sci. Rep."},{"key":"29688_CR24","unstructured":"Bonnert R. V., Dechering K. J., Hermkens P. H. H., Schalkwijk J., inventorsPantothenamide Analogues patent WO2020141155A1. 2020."},{"key":"29688_CR25","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1124\/dmd.112.046425","volume":"40","author":"L Di","year":"2012","unstructured":"Di, L. et al. A novel relay method for determining low-clearance values. Drug Metab. Dispos. 40, 1860\u20131865 (2012).","journal-title":"Drug Metab. Dispos."},{"key":"29688_CR26","doi-asserted-by":"publisher","first-page":"e30949","DOI":"10.1371\/journal.pone.0030949","volume":"7","author":"LM Sanz","year":"2012","unstructured":"Sanz, L. M. et al. P. falciparum in vitro killing rates allow to discriminate between different antimalarial mode-of-action. PLoS ONE 7, e30949 (2012).","journal-title":"PLoS ONE"},{"key":"29688_CR27","doi-asserted-by":"crossref","unstructured":"Summers R. L., et al. Chemogenomics identifies acetyl-coenzyme A synthetase as a target for malaria treatment and prevention. Cell Chem. Biol. 29, 191\u2013201.e8 (2021).","DOI":"10.1016\/j.chembiol.2021.07.010"},{"key":"29688_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10727","volume":"7","author":"SM Ganesan","year":"2016","unstructured":"Ganesan, S. M., Falla, A., Goldfless, S. J., Nasamu, A. S. & Niles, J. C. Synthetic RNA-protein modules integrated with native translation mechanisms to control gene expression in malaria parasites. Nat. Commun. 7, 10727 (2016).","journal-title":"Nat. Commun."},{"key":"29688_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-77644-4","volume":"11","author":"AS Nasamu","year":"2021","unstructured":"Nasamu, A. S. et al. An integrated platform for genome engineering and gene expression perturbation in Plasmodium falciparum. Sci. Rep. 11, 342 (2021).","journal-title":"Sci. Rep."},{"key":"29688_CR30","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1021\/acschembio.0c00369","volume":"15","author":"AL Herneisen","year":"2020","unstructured":"Herneisen, A. L. et al. Identifying the Target of an Antiparasitic Compound in Toxoplasma Using Thermal Proteome Profiling. ACS Chem. Biol. 15, 1801\u20131807 (2020).","journal-title":"ACS Chem. Biol."},{"key":"29688_CR31","doi-asserted-by":"crossref","unstructured":"Dziekan J. M., et al. Identifying purine nucleoside phosphorylase as the target of quinine using cellular thermal shift assay. Sci. Transl. Med. 11, eaau3174 (2019).","DOI":"10.1126\/scitranslmed.aau3174"},{"key":"29688_CR32","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1194\/jlr.M082891","volume":"59","author":"D Dubois","year":"2018","unstructured":"Dubois, D. et al. Toxoplasma gondii acetyl-CoA synthetase is involved in fatty acid elongation (of long fatty acid chains) during tachyzoite life stages. J. Lipid Res. 59, 994\u20131004 (2018).","journal-title":"J. Lipid Res."},{"key":"29688_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12915-020-00791-7","volume":"18","author":"J Kloehn","year":"2020","unstructured":"Kloehn, J. et al. Multi-omics analysis delineates the distinct functions of sub-cellular acetyl-CoA pools in Toxoplasma gondii. BMC Biol. 18, 67 (2020).","journal-title":"BMC Biol."},{"key":"29688_CR34","doi-asserted-by":"publisher","first-page":"4957","DOI":"10.1074\/jbc.M111.310144","volume":"287","author":"S Ramakrishnan","year":"2012","unstructured":"Ramakrishnan, S. et al. Apicoplast and endoplasmic reticulum cooperate in fatty acid biosynthesis in apicomplexan parasite Toxoplasma gondii. J. Biol. Chem. 287, 4957\u20134971. (2012).","journal-title":"J. Biol. Chem."},{"key":"29688_CR35","doi-asserted-by":"crossref","unstructured":"Prata I. O., et al. Plasmodium falciparum Acetyl-CoA Synthetase Is Essential for Parasite Intraerythrocytic Development and Chromatin Modification. ACS Infect. Dis. 7, 3224\u20133240 (2021).","DOI":"10.1021\/acsinfecdis.1c00414"},{"key":"29688_CR36","doi-asserted-by":"publisher","first-page":"e1004261","DOI":"10.1371\/journal.pcbi.1004261","volume":"11","author":"S Tymoshenko","year":"2015","unstructured":"Tymoshenko, S. et al. Metabolic Needs and Capabilities of Toxoplasma gondii through Combined Computational and Experimental Analysis. PLoS Comput Biol. 11, e1004261 (2015).","journal-title":"PLoS Comput Biol."},{"key":"29688_CR37","doi-asserted-by":"publisher","first-page":"e9569","DOI":"10.15252\/msb.20209569","volume":"16","author":"JM Bryant","year":"2020","unstructured":"Bryant, J. M. et al. Exploring the virulence gene interactome with CRISPR\/dCas9 in the human malaria parasite. Mol. Syst. Biol. 16, e9569 (2020).","journal-title":"Mol. Syst. Biol."},{"key":"29688_CR38","doi-asserted-by":"publisher","first-page":"4046","DOI":"10.1073\/pnas.0436428100","volume":"100","author":"CR White","year":"2003","unstructured":"White, C. R. & Seymour, R. S. Mammalian basal metabolic rate is proportional to body mass2\/3. Proc. Natl Acad. Sci. USA 100, 4046\u20134049 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"29688_CR39","doi-asserted-by":"publisher","first-page":"6068","DOI":"10.1128\/AAC.02538-14","volume":"58","author":"SM Senarathna","year":"2014","unstructured":"Senarathna, S. M. & Batty, K. T. Interspecies allometric scaling of antimalarial drugs and potential application to pediatric dosing. Antimicrob. Agents Chemother. 58, 6068\u20136078. (2014).","journal-title":"Antimicrob. Agents Chemother."},{"key":"29688_CR40","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1124\/dmd.110.037267","volume":"39","author":"SW Paine","year":"2011","unstructured":"Paine, S. W., Menochet, K., Denton, R., McGinnity, D. F. & Riley, R. J. Prediction of human renal clearance from preclinical species for a diverse set of drugs that exhibit both active secretion and net reabsorption. Drug Metab. Dispos. 39, 1008\u20131013 (2011).","journal-title":"Drug Metab. Dispos."},{"key":"29688_CR41","unstructured":"www.fda.gov."},{"key":"29688_CR42","doi-asserted-by":"publisher","first-page":"5792","DOI":"10.1128\/AAC.00287-13","volume":"57","author":"NJ White","year":"2013","unstructured":"White, N. J. Pharmacokinetic and pharmacodynamic considerations in antimalarial dose optimization. Antimicrob. Agents Chemother. 57, 5792\u20135807 (2013).","journal-title":"Antimicrob. Agents Chemother."},{"key":"29688_CR43","doi-asserted-by":"publisher","first-page":"17486","DOI":"10.1073\/pnas.1310402110","volume":"110","author":"R Rochford","year":"2013","unstructured":"Rochford, R. et al. Humanized mouse model of glucose 6-phosphate dehydrogenase deficiency for in vivo assessment of hemolytic toxicity. Proc. Natl Acad. Sci. USA 110, 17486\u201317491 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"29688_CR44","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.chembiol.2007.01.013","volume":"14","author":"YM Zhang","year":"2007","unstructured":"Zhang, Y. M. et al. Chemical knockout of pantothenate kinase reveals the metabolic and genetic program responsible for hepatic coenzyme A homeostasis. Chem. Biol. 14, 291\u2013302 (2007).","journal-title":"Chem. Biol."},{"key":"29688_CR45","doi-asserted-by":"crossref","unstructured":"McCarthy J. S., et al. Defining the Antimalarial Activity of Cipargamin in Healthy Volunteers Experimentally Infected with Blood-Stage Plasmodium falciparum. Antimicrob. Agents Chemother. 65, e01423\u201320 (2021).","DOI":"10.1128\/AAC.01423-20"},{"key":"29688_CR46","doi-asserted-by":"crossref","unstructured":"Brunschwig C., et al. UCT943, a Next-Generation Plasmodium falciparum PI4K Inhibitor Preclinical Candidate for the Treatment of Malaria. Antimicrob. Agents Chemother. 62, e00012\u2013e00018 (2018).","DOI":"10.1128\/AAC.01941-18"},{"key":"29688_CR47","doi-asserted-by":"publisher","first-page":"296ra111","DOI":"10.1126\/scitranslmed.aaa6645","volume":"7","author":"MA Phillips","year":"2015","unstructured":"Phillips, M. A. et al. A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria. Sci. Transl. Med. 7, 296ra111 (2015).","journal-title":"Sci. Transl. Med."},{"key":"29688_CR48","doi-asserted-by":"crossref","unstructured":"Murithi J. M., et al. The antimalarial MMV688533 provides potential for single-dose cures with a high barrier to Plasmodium falciparum parasite resistance. Sci. Transl. Med. 13, eabg6013 (2021).","DOI":"10.1126\/scitranslmed.abg6013"},{"key":"29688_CR49","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/S1473-3099(19)30611-5","volume":"20","author":"AH Gaur","year":"2020","unstructured":"Gaur, A. H. et al. Safety, tolerability, pharmacokinetics, and antimalarial efficacy of a novel Plasmodium falciparum ATP4 inhibitor SJ733: a first-in-human and induced blood-stage malaria phase 1a\/b trial. Lancet Infect. Dis. 20, 964\u2013975. (2020).","journal-title":"Lancet Infect. Dis."},{"key":"29688_CR50","doi-asserted-by":"crossref","unstructured":"McCarthy J. S., et al. A phase 1, placebo controlled, randomised, single ascending dose study and a volunteer infection study to characterize the safety, pharmacokinetics and antimalarial activity of the Plasmodium phosphatidylinositol 4-kinase inhibitor MMV390048. Clin. Infect. Dis. 71, e657\u2013e664 (2020).","DOI":"10.1093\/cid\/ciaa368"},{"key":"29688_CR51","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/nature14451","volume":"522","author":"B Baragana","year":"2015","unstructured":"Baragana, B. et al. A novel multiple-stage antimalarial agent that inhibits protein synthesis. Nature 522, 315\u2013320. (2015).","journal-title":"Nature"},{"key":"29688_CR52","doi-asserted-by":"publisher","first-page":"4478","DOI":"10.1021\/acs.jmedchem.0c01755","volume":"64","author":"J Guan","year":"2021","unstructured":"Guan, J. et al. Exploring Heteroaromatic Rings as a Replacement for the Labile Amide of Antiplasmodial Pantothenamides. J. Med Chem. 64, 4478\u20134497. (2021).","journal-title":"J. Med Chem."},{"key":"29688_CR53","unstructured":"MalariaGEN Pf3k project. https:\/\/www.malariagen.net\/data\/pf3k-5."},{"key":"29688_CR54","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.pt.2021.04.006","volume":"37","author":"M Duffey","year":"2021","unstructured":"Duffey, M. et al. Assessing risks of Plasmodium falciparum resistance to select next-generation antimalarials. Trends Parasitol. 37, 709\u2013721. (2021).","journal-title":"Trends Parasitol."},{"key":"29688_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/srep19722","volume":"6","author":"SA Cobbold","year":"2016","unstructured":"Cobbold, S. A., Santos, J. M., Ochoa, A., Perlman, D. H. & Llin\u00e1s, M. Proteome-wide analysis reveals widespread lysine acetylation of major protein complexes in the malaria parasite. Sci. Rep. 6, 19722 (2016).","journal-title":"Sci. Rep."},{"key":"29688_CR56","doi-asserted-by":"crossref","unstructured":"Vanheer L. N., Zhang H., Lin G., Kafsack B. F. C. Activity of Epigenetic Inhibitors against Plasmodium falciparum Asexual and Sexual Blood Stages. Antimicrob. Agents Chemother. 64, e02523\u201319 (2020).","DOI":"10.1128\/AAC.02523-19"},{"key":"29688_CR57","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3389\/fcimb.2017.00320","volume":"7","author":"CJ Ngwa","year":"2017","unstructured":"Ngwa, C. J. et al. Transcriptional Profiling Defines Histone Acetylation as a Regulator of Gene Expression during Human-to-Mosquito Transmission of the Malaria Parasite Plasmodium falciparum. Front Cell Infect. Microbiol. 7, 320 (2017).","journal-title":"Front Cell Infect. Microbiol."},{"key":"29688_CR58","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1128\/AAC.02721-13","volume":"58","author":"K Trenholme","year":"2014","unstructured":"Trenholme, K. et al. Lysine acetylation in sexual stage malaria parasites is a target for antimalarial small molecules. Antimicrob. Agents Chemother. 58, 3666\u20133678. (2014).","journal-title":"Antimicrob. Agents Chemother."},{"key":"29688_CR59","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1177\/0192623312448935","volume":"40","author":"AP Hall","year":"2012","unstructured":"Hall, A. P. et al. Liver hypertrophy: a review of adaptive (adverse and non-adverse) changes\u2013conclusions from the 3rd International ESTP Expert Workshop. Toxicol. Pathol. 40, 971\u2013994 (2012).","journal-title":"Toxicol. Pathol."},{"key":"29688_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/srep18704","volume":"5","author":"MW Vos","year":"2015","unstructured":"Vos, M. W. et al. A semi-automated luminescence based standard membrane feeding assay identifies novel small molecules that inhibit transmission of malaria parasites by mosquitoes. Sci. Rep. 5, 18704 (2015).","journal-title":"Sci. Rep."},{"key":"29688_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-015-1011-x","volume":"14","author":"V Dery","year":"2015","unstructured":"Dery, V. et al. An improved SYBR Green-1-based fluorescence method for the routine monitoring of Plasmodium falciparum resistance to anti-malarial drugs. Malar. J. 14, 481 (2015).","journal-title":"Malar. J."},{"key":"29688_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-12-424","volume":"12","author":"C Le Manach","year":"2013","unstructured":"Le Manach, C. et al. Fast in vitro methods to determine the speed of action and the stage-specificity of anti-malarials in Plasmodium falciparum. Malar. J. 12, 424 (2013).","journal-title":"Malar. J."},{"key":"29688_CR63","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1017\/S003118200005143X","volume":"93","author":"T Ponnudurai","year":"1986","unstructured":"Ponnudurai, T., Lensen, A. H., Meis, J. F. & Meuwissen, J. H. Synchronization of Plasmodium falciparum gametocytes using an automated suspension culture system. Parasitology 93, 263\u201374. (1986).","journal-title":"Parasitology"},{"key":"29688_CR64","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1093\/jac\/dkv003","volume":"70","author":"JM Bolscher","year":"2015","unstructured":"Bolscher, J. M. et al. A combination of new screening assays for prioritization of transmission-blocking antimalarials reveals distinct dynamics of marketed and experimental drugs. J. Antimicrob. Chemother. 70, 1357\u20131366 (2015).","journal-title":"J. Antimicrob. Chemother."},{"key":"29688_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05777-2","volume":"9","author":"MJ Delves","year":"2018","unstructured":"Delves, M. J. et al. A high throughput screen for next-generation leads targeting malaria parasite transmission. Nat. Commun. 9, 3805 (2018).","journal-title":"Nat. Commun."},{"key":"29688_CR66","doi-asserted-by":"publisher","first-page":"e2252","DOI":"10.1371\/journal.pone.0002252","volume":"3","author":"I Angulo-Barturen","year":"2008","unstructured":"Angulo-Barturen, I. et al. A murine model of falciparum-malaria by in vivo selection of competent strains in non-myelodepleted mice engrafted with human erythrocytes. PLoS One. 3, e2252 (2008).","journal-title":"PLoS One."},{"key":"29688_CR67","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/cyto.a.20647","volume":"75","author":"MB Jimenez-Diaz","year":"2009","unstructured":"Jimenez-Diaz, M. B. et al. Quantitative measurement of Plasmodium-infected erythrocytes in murine models of malaria by flow cytometry using bidimensional assessment of SYTO-16 fluorescence. Cytom. A. 75, 225\u2013235. (2009).","journal-title":"Cytom. A."},{"key":"29688_CR68","doi-asserted-by":"publisher","first-page":"4533","DOI":"10.1128\/AAC.00519-09","volume":"53","author":"MB Jimenez-Diaz","year":"2009","unstructured":"Jimenez-Diaz, M. B. et al. Improved murine model of malaria using Plasmodium falciparum competent strains and non-myelodepleted NOD-scid IL2Rgammanull mice engrafted with human erythrocytes. Antimicrob. Agents Chemother. 53, 4533\u20134536 (2009).","journal-title":"Antimicrob. Agents Chemother."},{"key":"29688_CR69","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1093\/infdis\/jiu271","volume":"210","author":"WJ Stone","year":"2014","unstructured":"Stone, W. J. et al. A scalable assessment of Plasmodium falciparum transmission in the standard membrane-feeding assay, using transgenic parasites expressing green fluorescent protein-luciferase. J. Infect. Dis. 210, 1456\u20131463 (2014).","journal-title":"J. Infect. Dis."},{"key":"29688_CR70","doi-asserted-by":"crossref","unstructured":"Rasmussen S. A., et al. Changing Antimalarial Drug Sensitivities in Uganda. Antimicrob. Agents Chemother. 61, e01516\u2013e015117 (2017).","DOI":"10.1128\/AAC.01516-17"},{"key":"29688_CR71","doi-asserted-by":"publisher","first-page":"e88","DOI":"10.1038\/psp.2013.71","volume":"3","author":"RN Upton","year":"2014","unstructured":"Upton, R. N. & Mould, D. R. Basic concepts in population modeling, simulation, and model-based drug development: part 3-introduction to pharmacodynamic modeling methods. CPT Pharmacomet. Syst. Pharmacol. 3, e88 (2014).","journal-title":"CPT Pharmacomet. Syst. Pharmacol."},{"key":"29688_CR72","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/nmeth.4223","volume":"14","author":"J Birnbaum","year":"2017","unstructured":"Birnbaum, J. et al. A genetic system to study Plasmodium falciparum protein function. Nat. Methods 14, 450\u2013456 (2017).","journal-title":"Nat. Methods"},{"key":"29688_CR73","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1093\/nar\/29.3.850","volume":"29","author":"K Deitsch","year":"2001","unstructured":"Deitsch, K., Driskill, C. & Wellems, T. Transformation of malaria parasites by the spontaneous uptake and expression of DNA from human erythrocytes. Nucleic Acids Res. 29, 850\u2013853 (2001).","journal-title":"Nucleic Acids Res."},{"key":"29688_CR74","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-11-312","volume":"11","author":"IA Vorobjev","year":"2012","unstructured":"Vorobjev, I. A. et al. Optimization of flow cytometric detection and cell sorting of transgenic Plasmodium parasites using interchangeable optical filters. Malar. J. 11, 312 (2012).","journal-title":"Malar. J."},{"key":"29688_CR75","doi-asserted-by":"publisher","first-page":"6635","DOI":"10.1128\/AAC.01224-16","volume":"60","author":"EL Allman","year":"2016","unstructured":"Allman, E. L., Painter, H. J., Samra, J., Carrasquilla, M. & Llinas, M. Metabolomic Profiling of the Malaria Box Reveals Antimalarial Target Pathways. Antimicrob. Agents Chemother. 60, 6635\u20136649. (2016).","journal-title":"Antimicrob. Agents Chemother."},{"key":"29688_CR76","doi-asserted-by":"publisher","first-page":"D463","DOI":"10.1093\/nar\/gkv1042","volume":"44","author":"M Sud","year":"2016","unstructured":"Sud, M. et al. Metabolomics Workbench: An international repository for metabolomics data and metadata, metabolite standards, protocols, tutorials and training, and analysis tools. Nucleic Acids Res. 44, D463\u2013D470 (2016).","journal-title":"Nucleic Acids Res."},{"key":"29688_CR77","doi-asserted-by":"publisher","first-page":"W537","DOI":"10.1093\/nar\/gky379","volume":"46","author":"E Afgan","year":"2018","unstructured":"Afgan, E. et al. The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2018 update. Nucleic Acids Res. 46, W537\u2013W44. (2018).","journal-title":"Nucleic Acids Res."},{"key":"29688_CR78","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.molbiopara.2004.05.009","volume":"137","author":"CJ Tonkin","year":"2004","unstructured":"Tonkin, C. J. et al. Localization of organellar proteins in Plasmodium falciparum using a novel set of transfection vectors and a new immunofluorescence fixation method. Mol. Biochem Parasitol. 137, 13\u201321 (2004).","journal-title":"Mol. Biochem Parasitol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-29688-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-29688-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-29688-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T12:00:22Z","timestamp":1669291222000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-29688-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,20]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["29688"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-29688-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.05.12.443866","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,20]]},"assertion":[{"value":"17 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"KJD and RWS hold stock in TropIQ Health Sciences B.V. PHHH is a consultant for TropIQ Health Sciences B.V, RB is a consultant for, and C.B., N.A., C.D.G., A.F., B.C., are employed by Medicines for Malaria Venture. Part of the data presented in this manuscript are included in patent application EP3674288A1, in the name of Medicines for Malaria Venture and with JS, PHHH, KJD and RVB as inventors. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2158"}}